Scoop has an Ethical Paywall
RMI welcomes panel report
RMI welcomes panel report
“The Researched Medicines Industry Association (RMI) welcomes the publication today of the Review of Access to High-Cost, Highly Specialised Medicines in New Zealand, released by the Hon Tony Ryall, Minister of Health.
“We will be taking time to study the recommendations in detail but we are encouraged that the panel have listened carefully and objectively to all the submissions made” says Denise Wood, Chief Executive.
“The PHARMAC model needs to evolve in order to address the ever increasing gap between New Zealand and the rest of the world in terms of access to medicines; the RMI looks forward to working with the Government on taking these recommendations forward.”
ENDS
Advertisement - scroll to continue reading
LAWA: “Know Before You Go” – Check Summer Swimming Water Quality Online
Official Aotearoa Music Charts: 2024 End Of Year Charts Have Been Published
Nielsen Book NZ: Nielsen BookData Announces 'In Too Deep' Is The Official New Zealand Number 1 Christmas Bestseller
PHARMAC: Pharmac Consulting On Six Medicines For New Zealanders
Athletics New Zealand: Funding Boost Propels Athletics NZ Toward LA 2028 Success
Te Whatu Ora Health New Zealand: Large Numbers Of RSE Workers Get Immunised To Protect Pacific Island Nations